Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
Clinical trial NCT04295863 · RECRUITING
Trial details
- NCT number
- NCT04295863
- Sponsor
- University of Chicago
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-25
- Primary completion
- 2026-04-12
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.